(Q39367965)

English

Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Reem Al-Sudairy

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Abdullah Al-Nasser

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Abdulrahman Alsultan

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Ali Al Ahmari

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Ibraheem Abosoudah

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Reema Al-Hayek

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Talal Al-Harbi

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Fahad Al-Manjomi

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Musa Al-Harbi

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hasna Al-Ghamdi

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Mohammed Al-Shahrani

11

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Asim F Belgaumi

12

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

12 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

74-80

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Epidemiology of diagnosed childhood cancer in Western Kenya

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Epidemiology of childhood cancer in India

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Epidemiology of childhood cancer

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Risk-adapted treatment of pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Treatment of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Nutritional status of children during treatment for acute lymphoblastic leukemia in the Central American Pediatric Hematology Oncology Association (AHOPCA): preliminary data from Guatemala.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Treatment refusal and abandonment in childhood acute lymphoblastic leukemia in Indonesia: an analysis of causes and consequences

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Time trend in frequency of occurrence of major immunophenotypes in paediatric acute lymphoblastic leukemia cases as experienced by Cancer Institute, Chennai, south India during the period 1989-2009.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Hypothesis: the environment is a major determinant of the immunological sub-type of lymphoma and acute lymphoblastic leukaemia in children

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Distribution of common genetic subgroups in childhood acute lymphoblastic leukemia in four developing countries

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Chi

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Overt testicular disease at diagnosis in childhood acute lymphoblastic leukemia: prognostic significance and role of testicular irradiation

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FPBC.24584

21 January 2018

Identifiers

10.1002/PBC.24584

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39367965&oldid=1874691318"